GMPR2
Basic information
Region (hg38): 14:24232422-24239242
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GMPR2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 16 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 16 | 0 | 0 |
Variants in GMPR2
This is a list of pathogenic ClinVar variants found in the GMPR2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-24233215-C-A | not specified | Uncertain significance (Sep 29, 2023) | ||
14-24233522-C-T | not specified | Uncertain significance (Oct 21, 2021) | ||
14-24233557-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
14-24233594-G-T | not specified | Uncertain significance (Mar 06, 2023) | ||
14-24235798-G-T | not specified | Uncertain significance (Jul 09, 2021) | ||
14-24236040-A-G | not specified | Uncertain significance (Nov 19, 2022) | ||
14-24236090-G-A | not specified | Uncertain significance (Aug 13, 2021) | ||
14-24236102-A-G | not specified | Uncertain significance (Jun 17, 2024) | ||
14-24236112-G-A | not specified | Uncertain significance (Aug 13, 2021) | ||
14-24237260-C-T | not specified | Uncertain significance (Apr 28, 2022) | ||
14-24238260-T-C | not specified | Uncertain significance (Dec 19, 2023) | ||
14-24238268-G-C | not specified | Uncertain significance (May 17, 2023) | ||
14-24238360-C-T | Uncertain significance (-) | |||
14-24238396-C-T | not specified | Uncertain significance (Jun 18, 2021) | ||
14-24238402-A-C | not specified | Uncertain significance (May 18, 2023) | ||
14-24238600-G-A | not specified | Uncertain significance (Mar 19, 2024) | ||
14-24238635-G-C | not specified | Uncertain significance (Apr 22, 2024) | ||
14-24238704-A-G | not specified | Uncertain significance (Dec 21, 2023) | ||
14-24238720-G-A | not specified | Uncertain significance (Jan 17, 2023) | ||
14-24238735-G-A | not specified | Uncertain significance (Dec 03, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GMPR2 | protein_coding | protein_coding | ENST00000420554 | 9 | 6821 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.03e-8 | 0.321 | 124731 | 0 | 95 | 124826 | 0.000381 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.800 | 177 | 210 | 0.845 | 0.0000106 | 2399 |
Missense in Polyphen | 65 | 78.441 | 0.82865 | 912 | ||
Synonymous | -0.261 | 78 | 75.1 | 1.04 | 0.00000383 | 726 |
Loss of Function | 0.705 | 14 | 17.1 | 0.816 | 8.50e-7 | 213 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000570 | 0.000570 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000389 | 0.000389 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000583 | 0.000583 |
Middle Eastern | 0.000389 | 0.000389 |
South Asian | 0.0000981 | 0.0000980 |
Other | 0.000495 | 0.000494 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the irreversible NADPH-dependent deamination of GMP to IMP. It functions in the conversion of nucleobase, nucleoside and nucleotide derivatives of G to A nucleotides, and in maintaining the intracellular balance of A and G nucleotides (PubMed:12009299, PubMed:12669231, PubMed:16359702, PubMed:22037469). Plays a role in modulating cellular differentiation (PubMed:12669231). {ECO:0000255|HAMAP- Rule:MF_03195, ECO:0000269|PubMed:12009299, ECO:0000269|PubMed:12669231, ECO:0000269|PubMed:16359702, ECO:0000269|PubMed:22037469}.;
- Pathway
- Purine metabolism - Homo sapiens (human);Metabolism of nucleotides;Metabolism;Nucleotide salvage;Purine salvage;Purine nucleotides nucleosides metabolism
(Consensus)
Recessive Scores
- pRec
- 0.249
Intolerance Scores
- loftool
- 0.454
- rvis_EVS
- -0.18
- rvis_percentile_EVS
- 40.16
Haploinsufficiency Scores
- pHI
- 0.0865
- hipred
- Y
- hipred_score
- 0.504
- ghis
- 0.559
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.997
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gmpr2
- Phenotype
Gene ontology
- Biological process
- purine nucleobase metabolic process;purine ribonucleotide interconversion;purine-containing compound salvage;GMP metabolic process;oxidation-reduction process
- Cellular component
- cytosol;GMP reductase complex
- Molecular function
- GMP reductase activity;metal ion binding